Rights and permissions
About this article
Cite this article
Edrecolomab: no additional value in colorectal cancer. Inpharma Wkly. 1352, 8 (2002). https://doi.org/10.2165/00128413-200213520-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213520-00014